Target Group Inc. (CBDY)
OTCMKTS · Delayed Price · Currency is USD
0.0018
-0.0001 (-5.26%)
At close: Dec 3, 2025
Target Group Revenue
Target Group had revenue of $499.65K in the quarter ending September 30, 2025, a decrease of -7.66%. This brings the company's revenue in the last twelve months to $5.00M, down -24.80% year-over-year. In the year 2024, Target Group had annual revenue of $6.59M with 77.19% growth.
Revenue (ttm)
5.00M
Revenue Growth
-24.80%
P/S Ratio
0.22
Revenue / Employee
119.08K
Employees
41
Market Cap
1.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.59M | 2.87M | 77.19% |
| Dec 31, 2023 | 3.72M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 30.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| Northwest Biotherapeutics | 937.00K |